This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mendes, R. E.
Right arrow Articles by Jones, R. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mendes, R. E.
Right arrow Articles by Jones, R. N.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 2004, p. 1433-1434, Vol. 48, No. 4
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.4.1433-1434.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

LETTER TO THE EDITOR

First Isolation of blaVIM-2 in Latin America: Report from the SENTRY Antimicrobial Surveillance Program


arrow
LETTER
 
Carbapenems, mainly imipenem and meropenem, are potent agents for the treatment of infections due to multiresistant Pseudomonas sp. clinical isolates. However, the prevalence of carbapenem resistance in this genus has been increasing worldwide. High-level resistance to carbapenems (>32 µg/ml) is still uncommon in Pseudomonas spp. but can be due to the presence of Ambler class B ß-lactamases—metallo-ß-lactamases (MBLs) (1). Three different clinically relevant types of mobile MBLs have been described in the literature: IMP, VIM, and SPM (2, 4; H. Kurokawa, T. Yagi, N. Shibata, K. Shibayama, and Y. Arakawa, Letter, Lancet 354:955, 1999). The VIM family has been reported mostly in European and Asian countries, although a distantly related MBL, VIM-7, has been characterized from the United States (5). We are not aware of VIM-type MBLs being reported from Latin America. In this work, we describe the presence of blaVIM-2-producing Pseudomonas sp. isolates and characterize their genetic context among isolates obtained from Latin American medical centers representing Chile and Venezuela.

Four isolates of Pseudomonas spp., one of P. fluorescens (43-14926) from a blood culture isolated in December 2002 in Santiago, Chile, and three of P. aeruginosa (49-4583, 49-4596, and 49-4597) recovered from respiratory tract samples between August and September 2002 from the same hospital in Caracas, Venezuela, were obtained as part of the SENTRY Antimicrobial Surveillance Program. According to results of MIC tests performed as described by the National Committee for Clinical Laboratory Standards, the isolates were resistant to all ß-lactams, aminoglycosides, quinolones, and other antimicrobial agents tested (Table 1). Only polymyxin B was active against all the isolates. MBL phenotypic tests were positive as judged by the disk approximation method (imipenem, meropenem, ceftazidime, EDTA, and 2-mercaptopropionic acid) and the Etest MBL strips (AB Biodisk, Solna, Sweden) (7). These results were confirmed by spectrophotometric assays measuring imipenem hydrolysis, as previously described (4). Imipenem hydrolysis was inhibited by 88 to 97% for each of the strains by EDTA (20 mM) (Table 2).


View this table:
[in this window]
[in a new window]
  		TABLE 1. Antimicrobial susceptibility profiles of the blaVIM-2-carrying Pseudomonas sp. isolates


View this table:
[in this window]
[in a new window]
  		TABLE 2. MICs by Etest MBL strips and imipenem hydrolytic activities (with and without EDTA) of the blaVIM-2-carrying Pseudomonas sp. isolates

Amplification with primers for the internal region of blaVIM-like genes and 5' conserved sequence and 3' conserved sequence from class 1 integron and subsequent sequencing were performed as described earlier (3, 5). Primers used for amplification and sequencing of the blaVIM gene were VIM-F (5'-AAAGTTATGCCGCACTCACC-3') and VIM-R (5'-TGCAACTTCATGTTATGCCG-3').

Sequencing results of the PCR amplicons revealed the presence of the blaVIM-2 gene in the first position of a class 1 integron, which has qacE{Delta}/su1l downstream of the MBL gene. This integron gene arrangement has been previously reported for a P. aeruginosa isolate from a patient in France in 1996 (3). Other cases have been reported from P. aeruginosa in Greece in 2000 and from Serratia marcescens in Korea in 2002 (6, 8). Class 1 integrons carrying blaVIM-type genes are now reported to contain genes encoding aminoglycoside-modifying enzymes, and it is uncertain whether the arrangement of the integron without the additional genes is the progenitor.

Despite repeated attempts, plasmid DNA analysis of the isolates did not show any plasmids, and transformation experiments were unsuccessful. Experiments in conjugation between the clinical isolates and Escherichia coli K-12 Rifr did not yield any transconjugants. These data imply that the blaVIM-2 found in these isolates is likely to be chromosomally carried. Automated ribotyping and pulsed-field gel electrophoresis showed that the three isolates from Venezuela are identical, suggesting clonal spread. The strain from Chile was unique and belonged to a different species from those of the other MBL-producing strains.

Dissemination of multiresistant bacteria coupled with the plasticity of class 1 integrons suggests that resistance to mainstay anti-Pseudomonas therapies, such as expanded-spectrum cephalosporins and carbapenems, will continue to increase. We urge greater local screening for MBL-producing strains with the disk approximation tests (8; Kurokawa et al., letter) and the Etest MBL strip (7).


arrow
REFERENCES
 
    1
  1. Bush, K. 1998. Metallo-ß-lactamases: a class apart. Clin. Infect. Dis. 27(Suppl.):S48-S53.
    2. 2
  2. Lauretti, L., M. L. Roccio, A. Mazzariol, G. Cornaglia, R. Fontana, and G. M. Rossolini. 1999. Cloning and characterization of blaVIM, a new integron-borne metallo-ß-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob. Agents Chemother. 43:1584-1590.[Abstract/Free Full Text]
    3. 3
  3. Poirel, L., T. Naas, D. Nicolas, L. Collet, S. Bellais, J. D. Cavallo, and P. Nordmann. 2000. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-ß-lactamase, and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44:891-897.[Abstract/Free Full Text]
    4. 4
  4. Toleman, M. A., A. M. Simm, T. A. Murphy, A. C. Gales, D. J. Biedenbach, R. N. Jones, and T. R. Walsh. 2002. Molecular characterization of SPM-1, a novel metallo-ß-lactamase isolated in Latin America: report from the SENTRY antimicrobial programme. J. Antimicrob. Chemother. 50:673-679.[Abstract/Free Full Text]
    5. 5
  5. Toleman, M. A., K. Rolston, R. N. Jones, and T. R. Walsh. 2004. blaVIM-7, an evolutionarily distinct metallo-ß-lactamase gene in a Pseudomonas aeruginosa isolate from the United States. Antimicrob. Agents Chemother. 48:329-332.[Abstract/Free Full Text]
    6. 6
  6. Tsakris, A., S. Pournaras, N. Woodford, M. F. Palepou, and G. S. Douboyas. 2000. Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-carbapenemase in Greece. J. Clin. Microbiol. 38:1290-1292.[Abstract/Free Full Text]
    7. 7
  7. Walsh, T. R., A. Bolmström, A. Qwärnström, and A. Gales. 2002. Evaluation of a new Etest for detecting metallo-ß-lactamases in routine clinical testing. J. Clin. Microbiol. 40:2755-2759.[Abstract/Free Full Text]
    8. 8
  8. Yum, J. H., D. Yong, K. Lee, H. S. Kim, and Y. Chong. 2002. A new integron carrying VIM-2 metallo-ß-lactamase gene cassette from a Serratia marcescens isolate. Diagn. Microbiol. Infect. Dis. 42:217-219.[CrossRef][Medline]
Rodrigo E. Mendes
Mariana Castanheira
Disciplina de Doencas Infecciosas e Parasitarias
Universidade Federal de Sao Paulo
Sao Paulo, Brazil

Patricia Garcia
Catholic University Hospital
Macul Santiago, Chile

Manuel Guzman
Centro Medico de Caracas
San Bernardio, Venezuela

Mark A. Toleman
Timothy R. Walsh*
Department of Pathology and Microbiology
University of Bristol
Bristol BS8 1TD, United Kingdom

Ronald N. Jones
The Jones Group
JMI Laboratories
North Liberty, Iowa

*Phone: 44 117 9288819 Fax: 44 117 9287896 E-mail: t.r.walsh{at}bristol.ac.uk

Antimicrobial Agents and Chemotherapy, April 2004, p. 1433-1434, Vol. 48, No. 4
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.4.1433-1434.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Strateva, T., Yordanov, D. (2009). Pseudomonas aeruginosa - a phenomenon of bacterial resistance. J Med Microbiol 58: 1133-1148 [Abstract] [Full Text]  
  • Li, H., Toleman, M. A., Bennett, P. M., Jones, R. N., Walsh, T. R. (2008). Complete Sequence of p07-406, a 24,179-Base-Pair Plasmid Harboring the blaVIM-7 Metallo-{beta}-Lactamase Gene in a Pseudomonas aeruginosa Isolate from the United States. Antimicrob. Agents Chemother. 52: 3099-3105 [Abstract] [Full Text]  
  • Mendes, R. E., Castanheira, M., Toleman, M. A., Sader, H. S., Jones, R. N., Walsh, T. R. (2007). Characterization of an Integron Carrying blaIMP-1 and a New Aminoglycoside Resistance Gene, aac(6')-31, and Its Dissemination among Genetically Unrelated Clinical Isolates in a Brazilian Hospital. Antimicrob. Agents Chemother. 51: 2611-2614 [Abstract] [Full Text]  
  • Mendes, R. E., Kiyota, K. A., Monteiro, J., Castanheira, M., Andrade, S. S., Gales, A. C., Pignatari, A. C. C., Tufik, S. (2007). Rapid Detection and Identification of Metallo-{beta}-Lactamase-Encoding Genes by Multiplex Real-Time PCR Assay and Melt Curve Analysis. J. Clin. Microbiol. 45: 544-547 [Abstract] [Full Text]  
  • Villegas, M. V., Lolans, K., del Rosario Olivera, M., Suarez, C. J., Correa, A., Queenan, A. M., Quinn, J. P., the Colombian Nosocomial Resistance Study Group, (2006). First Detection of Metallo-{beta}-Lactamase VIM-2 in Pseudomonas aeruginosa Isolates from Colombia. Antimicrob. Agents Chemother. 50: 226-229 [Abstract] [Full Text]  
  • Walsh, T. R., Toleman, M. A., Poirel, L., Nordmann, P. (2005). Metallo-{beta}-Lactamases: the Quiet before the Storm?. Clin. Microbiol. Rev. 18: 306-325 [Abstract] [Full Text]  
  • Toleman, M. A., Biedenbach, D., Bennett, D. M. C., Jones, R. N., Walsh, T. R. (2005). Italian metallo-{beta}-lactamases: a national problem? Report from the SENTRY Antimicrobial Surveillance Programme. J Antimicrob Chemother 55: 61-70 [Abstract] [Full Text]  
  • Castanheira, M., Toleman, M. A., Jones, R. N., Schmidt, F. J., Walsh, T. R. (2004). Molecular Characterization of a {beta}-Lactamase Gene, blaGIM-1, Encoding a New Subclass of Metallo-{beta}-Lactamase. Antimicrob. Agents Chemother. 48: 4654-4661 [Abstract] [Full Text]  
  • Mendes, R. E., Toleman, M. A., Ribeiro, J., Sader, H. S., Jones, R. N., Walsh, T. R. (2004). Integron Carrying a Novel Metallo-{beta}-Lactamase Gene, blaIMP-16, and a Fused Form of Aminoglycoside-Resistant Gene aac(6')-30/aac(6')-Ib': Report from the SENTRY Antimicrobial Surveillance Program. Antimicrob. Agents Chemother. 48: 4693-4702 [Abstract] [Full Text]  

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mendes, R. E.
Right arrow Articles by Jones, R. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mendes, R. E.
Right arrow Articles by Jones, R. N.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»